---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-23-001769"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:22:54.233938+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lexaria raises $1.57M in registered direct offering and private placement

## Summary
- Gross proceeds of $1.57M from sale of 889,272 shares at $0.97, pre-funded warrants for 729,058 shares at $0.9699, and private placement warrants for 1,618,330 shares at $0.97.
- Placement agent Maxim Group LLC receives 7% cash fee; offering closed October 3, 2023.
- Net proceeds to be used for R&D studies, patent costs, and general working capital.
- Officers and directors subject to 30-day lock-up from September 28, 2023.
- Private placement warrants exercisable after 6 months, expire 5.5 years; pre-funded warrants exercisable immediately.

## SEC filing metadata
- accession: 0001640334-23-001769
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001769/0001640334-23-001769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001769/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-23-001769
- JSON: https://secwatch.observer/filing/0001640334-23-001769.json
- Plain text: https://secwatch.observer/filing/0001640334-23-001769.txt

## Key facts
- Material Agreements
  Lexaria Bioscience Corp. entered into SPA with a certain institutional investor valued at $1,569,780.10 (effective 2023-09-28).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain institutional investor
  - Value: $1,569,780.10
  - Effective: 2023-09-28
  source text: On September 28, 2023, Lexaria Bioscience Corp., a Nevada corporation (the “Company”), entered into a securities purchase agreement (the “SPA”) with a certain institutional investor
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001769/0001640334-23-001769-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.